| 1 |
34954029 | FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways. | 2022 Jan |
2 |
| 2 |
35430559 | Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer. | 2022 Jun 5 |
1 |
| 3 |
33976187 | Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly. | 2021 May 11 |
1 |
| 4 |
34158341 | Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development. | 2021 Sep |
1 |
| 5 |
30665945 | The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer. | 2019 Mar |
1 |
| 6 |
31485633 | DNA‑PKcs PARylation regulates DNA‑PK kinase activity in the DNA damage response. | 2019 Oct |
1 |
| 7 |
28655785 | A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia. | 2017 Oct |
1 |
| 8 |
29262611 | PARP inhibition causes premature loss of cohesion in cancer cells. | 2017 Nov 28 |
1 |
| 9 |
25302833 | New therapeutic perspectives in CCDC6 deficient lung cancer cells. | 2015 May 1 |
1 |
| 10 |
26180927 | Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer. | 2015 Jul 28 |
2 |
| 11 |
24240700 | Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity. | 2014 Jan 1 |
1 |
| 12 |
23934192 | A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer. | 2013 Nov 21 |
2 |
| 13 |
24252502 | ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition. | 2013 Nov 19 |
1 |
| 14 |
22194930 | Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil. | 2011 |
2 |